EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer

Min-A Kim iD, Johyeon Nam iD, Ha-Yeon Shin iD, Jue Young Kim iD, Anna Jun, Hanbyoul Cho iD, Mi-Ryung Han, Jae-Hoon Kim iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Min-A Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neoplasm Recurrence, Local, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation (NRF) of Korea, Korea National Institute of Health, Basic Science Research Program through the National Research Foundation (NRF) of Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian cancer (HGSOC) is the most prevalent and aggressive form of epithelial ovarian cancer and is characterized by high recurrence rates and poor clinical outcomes. In this study, we identify molecular signatures associated with recurrence by conducting integrative transcriptomic and proteomic analyses on paired primary and recurrent HGSOC tissues from 34 patients. RNA sequencing and proteomic profiling revealed 185 differentially expressed genes (DEGs) and 36 differentially expressed proteins (DEPs) linked to recurrence. Pathway enrichment and Ingenuity pathway analyses highlighted the involvement of immune cell trafficking, cell signaling, and MAPK pathway activation in recurrent tumors. A survival analysis identified seven DEGs that correlated significantly with recurrence-free survival; among them, IL7R, IRF8, and PTPRC were upregulated in recurrent tumors and associated with poor prognosis, and NSG1 was downregulated and linked to favorable outcomes. Immunohistochemistry validated the differential expression of these markers at the protein level. The proteomic analysis demonstrated that recurrent tumor-specific DEGs are functionally linked to MAPK signaling. Co-expression analyses revealed dynamic regulatory interactions between the DEGs and DEPs, suggesting context-dependent molecular shifts during recurrence. This integrative multi-omics approach reveals that key molecular alterations underlie HGSOC recurrence and identifies IL7R, IRF8, PTPRC, and NSG1 as potential prognostic biomarkers and therapeutic targets. Our findings provide a foundation for targeted strategies to improve outcomes for patients with recurrent HGSOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsNeoplasm Recurrence, LocalCystadenocarcinoma, SerousHumansFemaleMultiomicsProteomicsGene Expression Regulation, NeoplasticGene Expression ProfilingPrognosisBiomarkers, TumorTranscriptomeNeoplasm Grading

Stichwörter der Autor:innen

high-grade serous ovarian cancerproteomicsrecurrencetranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea.
  • Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22014, Republic of Korea.
  • Institute for New Drug Development, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22014, Republic of Korea.

ORCID-Profile: Min-A Kim, Johyeon Nam, Ha-Yeon Shin, Jue Young Kim, Hanbyoul Cho, Jae-Hoon Kim

Förderung

  • National Research Foundation (NRF) of Korea
  • Korea National Institute of Health
  • Basic Science Research Program through the National Research Foundation (NRF) of Republic of Korea
  • Ministry of Education
  • the National Research Foundation of Korea (NRF) grant funded by the Korea government

Zitieren

APA

Kim, M. A., Nam, J., Shin, H. Y., Kim, J. Y., Jun, A., Cho, H., Han, M. R., & Kim, J. H. (2026). Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020948

Vancouver

Kim MA, Nam J, Shin HY, Kim JY, Jun A, Cho H, et al. Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020948

BibTeX
@article{Kim2026,
  author = {Kim, Min-A and Nam, Johyeon and Shin, Ha-Yeon and Kim, Jue Young and Jun, Anna and Cho, Hanbyoul and Han, Mi-Ryung and Kim, Jae-Hoon},
  title = {Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020948}
}
Kostenlos starten →